Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community (Q43438089)

23 November 2017

Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community (English)

1 reference

23 November 2017

0 references

0 references

0 references

1 reference

2

1 reference

23 November 2017

Ostgren CJ

1

1 reference

PubMed ID

15287930

23 November 2017

Råstam L

series ordinal

3

1 reference

PubMed ID

15287930

23 November 2017

Lindblad U

series ordinal

4

1 reference

23 November 2017

1 September 2004

1 reference

Diabetes, Obesity and Metabolism

23 November 2017

1 reference

23 November 2017

6

1 reference

23 November 2017

367-374

1 reference

23 November 2017

5

1 reference

ABC of atrial fibrillation. History, epidemiology, and importance of atrial fibrillation

23 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-8902.2004.00358.X

Atrial fibrillation in elderly patients: prevalence and comorbidity in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-8902.2004.00358.X

Prevalence of atrial fibrillation and association of atrial fibrillation with prior and new thromboembolic stroke in older patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-8902.2004.00358.X

A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-8902.2004.00358.X

Risk factor clustering in patients with hypertension and non-insulin-dependent diabetes mellitus. The Skaraborg Hypertension Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-8902.2004.00358.X

Associations between smoking and beta-cell function in a non-hypertensive and non-diabetic population. Skaraborg Hypertension and Diabetes Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-8902.2004.00358.X

Differences in treatment and metabolic abnormalities between normo- and hypertensive patients with type 2 diabetes: the Skaraborg Hypertension and Diabetes Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-8902.2004.00358.X

Impaired glucose metabolism and obesity in Swedish patients with borderline isolated systolic hypertension: Skaraborg Hypertension and Diabetes Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-8902.2004.00358.X

Smoking and other risk factors for coronary heart-disease in British civil servants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-8902.2004.00358.X

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-8902.2004.00358.X

Clustering of cardiovascular disease risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-8902.2004.00358.X

Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-8902.2004.00358.X

Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-8902.2004.00358.X

10.1111/J.1462-8902.2004.00358.X

21 January 2018

Identifiers

DOI

1 reference

23 November 2017

1 reference

PubMed ID

15287930